Skip to main navigation Skip to search Skip to main content

Pediatric anti-N-methyl-D-aspartate receptor encephalitis - Clinical analysis and novel findings in a series of 20 patients

  • Thaís Armangue
  • , Maarten J. Titulaer
  • , Ignacio Málaga
  • , Luis Bataller
  • , Iñigo Gabilondo
  • , Francesc Graus
  • , Josep Dalmau*
  • *Corresponding author for this work
  • University of Barcelona
  • Autonomous University of Barcelona
  • Hospital Universitario Central de Asturias
  • Hospital Universitario La Fe
  • University of Pennsylvania

Research output: Contribution to journal › Article › Academic › peer-review

385 Citations (Scopus)

Abstract

Objective: 

To report the clinical features of 20 pediatric patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. 

Study design: 

Review of clinical data, long-term follow-up, and immunologic studies performed in a single center in Spain in the last 4 years.

Results: 

The median age of the patients was 13 years (range, 8 months-18 years), 70% were female. In 12 patients (60%), the initial symptoms were neurologic, usually dyskinesias or seizures, and in the other 40% psychiatric. One month into the disease, all patients had involuntary movements and alterations of behavior and speech. All patients received steroids, intravenous immunoglobulin or plasma exchange, and 7 rituximab or cyclophosphamide. With a median follow up of 17.5 months, 85% had substantial recovery, 10% moderate or severe deficits, and 1 died. Three patients had previous episodes compatible with anti-NMDAR encephalitis, 2 of them with additional relapses after the diagnosis of the disorder. Ovarian teratoma was identified in 2 patients, 1 at onset of encephalitis and the other 1 year later. Two novel observations (1 patient each) include, the identification of an electroencephalographic pattern ("extreme delta brush") considered characteristic of this disorder, and the development of anti-NMDAR encephalitis as post herpes simplex encephalitis choreoathetosis. 

Conclusions: 

The initial symptoms of pediatric anti-NMDAR encephalitis vary from those of the adults (more neurologic and less psychiatric in children), the development of a mono-symptomatic illness is extremely rare (except in relapses), and most patients respond to treatment. Our study suggests a link between post herpes simplex encephalitis choreoathetosis and anti-NMDAR encephalitis.

Original languageEnglish
Pages (from-to)850-856.e2
JournalJournal of Pediatrics
Volume162
Issue number4
DOIs
Publication statusPublished - Apr 2013
Externally publishedYes

Bibliographical note

Funding Information:
Supported by the National Institutes of Health ( RO1NS077851 and RO1MH094741 to J.D.), the National Cancer Institute ( RO1CA89054 to J.D.), Fundació la Marató de TV3 (to J.D.), Fondo de Investigaciones Sanitarias ( PI11/01780 to J.D. and PS09/0193 to F.G.), a fellowship from the Dutch Cancer Society (KWF 2009-4451), and a McKnight Neuroscience of Brain Disorders award (to J.D.). J.D. has received a research grant from Euroimmun , and receives royalties from the Editorial Board of Up-To-Date and from patents for the use of Ma2 and NMDAR as autoantibody tests. The authors declare no conflicts of interest.

Fingerprint

Dive into the research topics of 'Pediatric anti-N-methyl-D-aspartate receptor encephalitis - Clinical analysis and novel findings in a series of 20 patients'. Together they form a unique fingerprint.

Cite this